RxDoctor Payments DataLook up a doctor →

Ronald Brazg

Endocrinology, Diabetes & Metabolism · Renton, WANPI 1194746131

Payments from drug & device makers

$17,886,646in general payments, 2019–2025

Across 1,993 payments — averaging $8974.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$5M
  • Medtronic$4.1M
  • Senseonics, Incorporated$2.7M
  • Modernatx, Inc.$2.4M
  • Eli Lilly$1.3M
  • Roche Diabetes Care, Inc.$1.1M
  • plus $1.3M from 7 others
$99,058in research payments, 2019–2025

Across 107 payments — averaging $925.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$53K
  • Eli Lilly$38K
  • Senseonics, Incorporated$7K
  • AbbVie$2K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott669$4,993,529
Medtronic(2 entities)240$4,087,515
Senseonics, Incorporated58$2,690,154
Modernatx, Inc.32$2,440,269
Eli Lilly66$1,303,909
Roche Diabetes Care, Inc.30$1,066,818
Novo Nordisk AS790$571,388
AbbVie(2 entities)60$418,253
Pfizer25$242,453
Sanofi US Services Inc.12$56,106
Janssen Research & Development, LLC9$14,068
Acella Pharmaceuticals, LLC1$1,185
Lexicon Pharmaceuticals, Inc.1$1,000

How this compares

$17,886,646 in reported general payments places this provider in the 95th percentile of 161 endocrinology, diabetes & metabolism providers in Washington.

See all endocrinology, diabetes & metabolism providers in Washington

Other endocrinology, diabetes & metabolism in Renton

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →